Untargeted screening of urinary peptides with liquid chromatography coupled to hybrid linear-ion trap tandem mass spectrometry

被引:1
作者
Sauvage, Francois-Ludovic [1 ,2 ]
Gastinel, Louis Noel [2 ,3 ]
Marquet, Pierre [1 ,2 ,3 ]
机构
[1] Univ Hosp, Dept Pharmacol Toxicol, CHU Limoges, F-87042 Limoges, France
[2] INSERM, UMR S850, Limoges, France
[3] Univ Limoges, F-87065 Limoges, France
关键词
Clinical proteomics; LC-MS/MS; Solid-phase extraction; BIOMARKERS; PROTEOMICS; DISCOVERY; IDENTIFICATION; PEPTIDOMICS; VALIDATION; MS;
D O I
10.1016/j.chroma.2012.04.006
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We formerly developed and applied a liquid chromatography coupled with hybrid triple quadrupole-linear ion trap mass spectrometry technique for the detection and identification of exogenous compounds in clinical and forensic toxicology. In this study, we aimed to adapt this technique to the detection and identification of the constituents of the urinary peptidome. After solid-phase extraction, separation was performed using gradient reversed-phase liquid chromatography. The mass spectrometer was operated in the information-dependent acquisition mode. switching between: a survey scan acquired in the enhanced multi-charged scan mode with dynamic subtraction of background noise; and two dependent scans obtained in the enhanced product ion scan mode. The results obtained show that: (i) the present procedure is able to detect and identify peptides which, together with their inferred parent proteins, are similar to those referenced in the related literature: (ii) the structure of some peptides can generally be resolved from their enhanced product ion spectra; and (iii) confirmation of the sequences proposed through library search by in silico verification of the fragments observed in the enhanced product ion spectra seems to be indispensable to avoid misinterpretations. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:138 / 147
页数:10
相关论文
共 34 条
  • [1] Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma
    Addona, Terri A.
    Abbatiello, Susan E.
    Schilling, Birgit
    Skates, Steven J.
    Mani, D. R.
    Bunk, David M.
    Spiegelman, Clifford H.
    Zimmerman, Lisa J.
    Ham, Amy-Joan L.
    Keshishian, Hasmik
    Hall, Steven C.
    Allen, Simon
    Blackman, Ronald K.
    Borchers, Christoph H.
    Buck, Charles
    Cardasis, Helene L.
    Cusack, Michael P.
    Dodder, Nathan G.
    Gibson, Bradford W.
    Held, Jason M.
    Hiltke, Tara
    Jackson, Angela
    Johansen, Eric B.
    Kinsinger, Christopher R.
    Li, Jing
    Mesri, Mehdi
    Neubert, Thomas A.
    Niles, Richard K.
    Pulsipher, Trenton C.
    Ransohoff, David
    Rodriguez, Henry
    Rudnick, Paul A.
    Smith, Derek
    Tabb, David L.
    Tegeler, Tony J.
    Variyath, Asokan M.
    Vega-Montoto, Lorenzo J.
    Wahlander, Asa
    Waldemarson, Sofia
    Wang, Mu
    Whiteaker, Jeffrey R.
    Zhao, Lei
    Anderson, N. Leigh
    Fisher, Susan J.
    Liebler, Daniel C.
    Paulovich, Amanda G.
    Regnier, Fred E.
    Tempst, Paul
    Carr, Steven A.
    [J]. NATURE BIOTECHNOLOGY, 2009, 27 (07) : 633 - U85
  • [2] Mass spectrometry-based proteomics
    Aebersold, R
    Mann, M
    [J]. NATURE, 2003, 422 (6928) : 198 - 207
  • [3] A new strategy for faster urinary biomarkers identification by Nano-LC-MALDI-TOF/TOF mass spectrometry
    Benkali, K.
    Marquet, P.
    Rerolle, J. P.
    Le Meur, Y.
    Gastinel, L. N.
    [J]. BMC GENOMICS, 2008, 9 (1)
  • [4] Biomarkers in renal transplantation
    Bestard, Oriol
    Cruzado, Josep M.
    la Franquesa, Marcel
    Grinyo, Josep M.
    [J]. CURRENT OPINION IN ORGAN TRANSPLANTATION, 2010, 15 (04) : 467 - 473
  • [5] Assessment of high-throughput high-resolution MALDI-TOF-MS of urinary peptides for the detection of muscle-invasive bladder cancer
    Bryan, Richard T.
    Wei, Wenbin
    Shimwell, Neil J.
    Collins, Stuart I.
    Hussain, Syed A.
    Billingham, Lucinda J.
    Murray, Paul G.
    Deshmukh, Nayneeta
    James, Nicholas D.
    Wallace, D. Michael A.
    Johnson, Philip J.
    Zeegers, Maurice P.
    Cheng, K. K.
    Martin, Ashley
    Ward, Douglas G.
    [J]. PROTEOMICS CLINICAL APPLICATIONS, 2011, 5 (9-10) : 493 - 503
  • [6] Advances in top-down proteomics for disease biomarker discovery
    Calligaris, David
    Villard, Claude
    Lafitte, Daniel
    [J]. JOURNAL OF PROTEOMICS, 2011, 74 (07) : 920 - 934
  • [7] CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics
    Coon, Joshua J.
    Zuerbig, Petra
    Dakna, Mohammed
    Dominicza, Anna F.
    Decramer, Stephane
    Fliser, Danilo
    Frommberger, Moritz
    Golovko, Igor
    Good, David M.
    Herget-Rosenthal, Stefan
    Jankowski, Joachim
    Julian, Bruce A.
    Kellmann, Markus
    Kolch, Walter
    Massy, Ziad
    Novak, Jan
    Rossing, Kasper
    Schanstra, Joost P.
    Schiffer, Eric
    Theodorescu, Dan
    Vanholder, Raymond
    Weissinger, Eva M.
    Mischak, Harald
    Schmitt-Kopplin, Philippe
    [J]. PROTEOMICS CLINICAL APPLICATIONS, 2008, 2 (7-8) : 964 - 973
  • [8] Court M., 2011, PROTEOM CLIN APPL, V5, P547
  • [9] Urine in Clinical Proteomics
    Decramer, Stephane
    de Peredo, Anne Gonzalez
    Breuil, Benjamin
    Mischak, Harald
    Monsarrat, Bernard
    Bascands, Jean-Loup
    Schanstra, Joost P.
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2008, 7 (10) : 1850 - 1862
  • [10] Selected reaction monitoring applied to proteomics
    Gallien, Sebastien
    Duriez, Elodie
    Domon, Bruno
    [J]. JOURNAL OF MASS SPECTROMETRY, 2011, 46 (03): : 298 - 312